XPHARM
Live / Allowed — Notice of allowance issued (as of 18 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Feb 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99057385
- Mark type
- Stylized text
- Filed
- 26 Feb 2025
- Published for opposition
- 23 Sept 2025
- Attorney of record
- Kathleen A. Tyrrell
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cystic fibrosis, type 2 diabetes, dry eye disease, lipid imbalances, sickle cell disease and hypertriglyceridemia; pharmaceutical products containing fatty acid blends for the treatment of cystic fibrosis, type 2 diabetes, dry eye disease, lipid imbalances, sickle cell disease and hypertriglyceridemia; pharmaceutical products for the treatment of lipid imbalances; pharmaceutical products for the treatment of sickle cell disease
Owner
- Lobe Sciences Ltd., Stuart, FL, CA
- Lobe Sciences Ltd., Stuart, FL, CA
Prosecution history
- 18 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 23 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Sept 2025 — PUBLISHED FOR OPPOSITION
- 17 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Aug 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 01 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Aug 2025 — NON-FINAL ACTION E-MAILED
- 01 Aug 2025 — NON-FINAL ACTION WRITTEN
- 31 Jul 2025 — ASSIGNED TO EXAMINER
- 26 Feb 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 26 Feb 2025 — APPLICATION FILING RECEIPT MAILED
- 26 Feb 2025 — NEW APPLICATION ENTERED